COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 2958: Articles 29571-29580  | Next

Estimating the Final Epidemic Size for COVID-19 Outbreak using Improved Epidemiological Models
Ranjan, R.
10.1101/2020.04.12.20061002 — Posted: 2020-04-16 Discussion: Onsite
Impact of population mask wearing on Covid-19 post lockdown
Javid, B., Balaban, N. Q.
10.1101/2020.04.13.20063529 — Posted: 2020-04-16 Discussion: Onsite
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy
Giorgi Rossi, P., Marino, M., Formisano, D., Venturelli, F., Vicentini, M., Grilli, R., The Reggio Emilia COVID-19 Working Group
10.1101/2020.04.13.20063545 — Posted: 2020-04-16
Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
Castro, V. M., Ross, R. A., McBride, S. M., Perlis, R. H.
10.1101/2020.04.11.20061994 — Posted: 2020-04-16 Discussion: Onsite
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis
Shamshirian, A., Heydari, K., Alizadeh-Navaei, R., Moosazadeh, M., Abrotan, S., Hessami, A.
10.1101/2020.04.12.20062869 — Posted: 2020-04-16
COVID-19-related mortality by age groups in Europe: A meta-analysis
Cohen, J. F., Korevaar, D. A., Matczak, S., Brice, J., Chalumeau, M., Toubiana, J.
10.1101/2020.04.11.20061721 — Posted: 2020-04-16
Prediction of the time evolution of the COVID-19 disease in Guadeloupe with a stochastic evolutionary model
ALLALI, M., PORTECOP, P., CARLES, M., GIBERT, D.
10.1101/2020.04.12.20063008 — Posted: 2020-04-16
AN EPIDEMIOLOGICAL MODEL TO AID DECISION-MAKING FOR COVID-19 CONTROL IN SRI LANKA
Ediriweera, D. S., de Silva, N. R., Malavige, N. G., de Silva, H. J.
10.1101/2020.04.11.20061481 — Posted: 2020-04-16
Designing a multi-epitope peptide-based vaccine against SARS-CoV-2
Singh, A., Thakur, M., Sharma, L. K., Chandra, K.
10.1101/2020.04.15.040618 — Posted: 2020-04-16 Discussion: Onsite
COVID-19 is an emergent disease of aging
Santesmasses, D., Castro, J. P., Zenin, A. A., Shindyapina, A. V., Gerashchenko, M. V., Zhang, B., Kerepesi, C., Yim, S. H., Fedichev, P. O., Gladyshev, V. N.
10.1101/2020.04.15.20060095 — Posted: 2020-04-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).